Coverage
-
April 24, 2018
A New York federal judge on Tuesday ruled that Valeant Pharmaceuticals International Inc. and others sued in a Manhattan federal court by three investment funds over alleged fraud and price-gouging can transfer the suit to New Jersey, where they already face 27 similar suits.
3 other articles on this case.
View all »